Share on StockTwits
 

NMC Health PLC (LON:NMC)‘s stock had its “buy” rating reiterated by analysts at Numis Securities Ltd in a research report issued to clients and investors on Tuesday, American Banking & Market News reports. They currently have a GBX 560 ($9.31) target price on the stock. Numis Securities Ltd’s target price indicates a potential upside of 25.20% from the stock’s previous close.

Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of NMC Health PLC in a research note on Wednesday, November 27th. They now have a GBX 430 ($7.15) price target on the stock.

NMC Health PLC (LON:NMC) opened at 458.46 on Tuesday. NMC Health PLC has a one year low of GBX 256.744 and a one year high of GBX 505.50. The stock has a 50-day moving average of GBX 465.8 and a 200-day moving average of GBX 386.5.

NMC Health plc is a holding company. The Company is an integrated healthcare provider in the United Arab Emirates market.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.